Health-care companies were more or less flat as traders rotated out of the high-risk tech sector into defensive areas.
Health-care companies were more or less flat as traders rotated out of the high-risk tech sector into defensive areas.
Eli Lilly launched its Foundayo weight-loss pill in the U.K., making the country the first in Europe to offer the oral treatment.
Moderna slipped but remained sharply higher for the year to date as investors remained optimistic about a breakthrough of RNA technology in oncology.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
Health-care companies were more or less flat as traders rotated into laggards from the volatile technology sector.
Health-care companies were more or less flat as traders rotated back into risky corners of the market.
Health-care companies were more or less flat as traders rotated into the defensive sector ahead of jobs data.
Health-care companies rose as traders rotated into defensive sectors due to volatility in oil and Treasury markets.
Health-care companies rose, but not by as much as the broad market, as traders rotated back into the tech sector.
Health-care companies fell as traders rotated out of defensive sectors and back into the tech sector.
